6
Oct
2026

GMEP medical technology GmbH

Exhibitor at CPHI Milan 2026 stand 20F70, Finished Dosage & Formulation
About Us

GMEP is an international pharmaceutical company with our innovative respiratory drug Ambrospray. We are looking for distributors worldwide and looking forward to get in contact with new partners.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20F70, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Ambroxol oral Spray

    Product Ambroxol oral Spray

    Ambrospray®  is the innovative and unique product, it's the only oral spray form of Ambroxol in the world. It is convenient to carry and use, it has accurate drug delivery and take effect very fast, It has a wide target group and usage scenes. It is produced in EU with the best quality. We are looking...

GMEP Medical Technology GmbH Resources (1)

  • LINKEDIN

    Brochure LINKEDIN

    We are a group of international pharmaceutical professional, with more than 10 years expertise in global pharmaceutical distribution, marketing and sales.